Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CARM1 | Q86X55 | 2/20 | 0.62 |
| ▸ | PRMT6 | Q96LA8 | 2/20 | 0.62 |
| ▸ | PRMT8 | Q9NR22 | 2/20 | 0.62 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19993069 | 0.92 | CARM1 (0.65) | CARM1PRMT6PRMT8PRMT1HPGD | |
| SCHEMBL2703833 | 0.87 | CARM1 (0.48) | CARM1PRMT6PRMT8PRMT1HPGD | |
| SCHEMBL46511 | 0.86 | HPGD (0.58) | CARM1PRMT6PRMT8HPGDDUSP3 | |
| Hydrochloric Acid SCHEMBL11543252 | 0.85 | HPGD (0.56) | CARM1PRMT6PRMT8HPGDDUSP3 | |
| SCHEMBL10143861 | 0.85 | KEAP1 (0.52) | CARM1PRMT6PRMT8HPGDDUSP3 | |
| Hydrochloric Acid SCHEMBL2493592 | 0.85 | HPGD (0.56) | CARM1PRMT6PRMT8HPGDDUSP3 | |
| SCHEMBL7103505 | 0.83 | PAOX (0.53) | CARM1PRMT6PRMT8HPGDDUSP3 | |
| Methylamine SCHEMBL7979606 | 0.83 | SMN1; SMN2 (0.55) | CARM1PRMT6PRMT8HPGDDUSP3 | |
| Trifluoroacetic Acid SCHEMBL28556555 | 0.82 | TDP1 (0.47) | CARM1PRMT6PRMT8HPGDDUSP3 | |
| SCHEMBL18731410 | 0.82 | CA12 (0.47) | CARM1PRMT6PRMT8HPGDDUSP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2885 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260055619-A1 | WATERPROOF ADHESIVE COMPOSITIONS AND FLOORING SYSTEMS | DICKENS CARROLL BENFORD (US) | 2026-02-26 | — | — | US | claimed |
| CN-119799151-A | Polyurethane coating for road marking and preparation method thereof | 万华化学集团股份有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-119240734-A | SAPO-5 molecular sieve, and preparation method and application thereof | 中国石油化工股份有限公司 | 2025-01-03 | — | — | CN | claimed |
| CN-119219023-A | Spherical SAPO-5 molecular sieve, and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-12-31 | — | — | CN | claimed |
| CN-118879293-A | Degradable nano silicon dioxide oil displacement agent with surface activity and application thereof | 中国海洋石油集团有限公司 | 2024-11-01 | — | — | CN | claimed |
| CN-118146503-A | Non-isocyanate polyurethane and preparation method thereof, anticorrosive paint containing non-isocyanate polyurethane and preparation method thereof | 山西省建筑科学研究院集团有限公司 | 2024-06-07 | — | — | CN | claimed |
| US-20240182441-A1 | 2-(2,4,5-SUBSTITUTED-ANILINO)PYRIMIDINE COMPOUNDS | ASTRAZENECA AB (SE) | 2024-06-06 | — | — | US | claimed |
| WO-2024002938-A1 | COMBINATIONS INVOLVING EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCER | ASTRAZENECA AB (SE) | 2024-01-04 | — | — | WO | claimed |
| CN-117180120-A | Skin-moistening bath lotion and preparation method thereof | 胡侠 | 2023-12-08 | — | — | CN | claimed |
| WO-2023187037-A1 | EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) TYROSINE KINASE INHIBITORS IN COMBINATION WITH AN AKT INHIBITOR FOR THE TREATMENT OF CANCER | ASTRAZENECA AB (SE) | 2023-10-05 | — | — | WO | claimed |
| EP-0412907-B1 | New organic acid esters of alcoholic derivatives of 19-nor steroids and their salts, process for their preparation and intermediates thereof, their use as medicines and pharmaceutical compositions containing them | ROUSSEL UCLAF (FR) | 1994-11-09 | — | — | EP | claimed |
| US-5071636-A | Polyaminedithiol compounds; nuclear imaging of regional cerebral blood flow | NIHON MEDI-PHYSICS CO., LTD. (JP) | 1991-12-10 | — | — | US | claimed |
| EP-0283375-B1 | PROCESS FOR THE PREPARATION OF POLYCHLOROPHOSPHAZENE | ELF ATOCHEM S.A. (FR) | 1991-10-30 | — | — | EP | claimed |
| US-5047432-A | Antidepressants | THE BOOTS COMPANY PLC (GB) | 1991-09-10 | — | — | US | claimed |
| CN-1049352-A | The alcohol derivate of using the 19-norsteroid prepares the method for new organic acid acetic and salt thereof | ROUSSEL UCLAF (FR) | 1991-02-20 | — | — | CN | claimed |
| US-4925901-A | STORAGE STAABILITY, ONIUM ION CATALYST | THE DOW CHEMICAL COMPANY (US) | 1990-05-15 | — | — | US | claimed |
| EP-0322876-A2 | Chelating compounds and their use | NIHON MEDI-PHYSICS CO., LTD. (JP) | 1989-07-05 | — | — | EP | claimed |
| US-4810480-A | Preparation of polychlorophosphazene | ATOCHEM (FR) | 1989-03-07 | — | — | US | claimed |
| EP-0191542-B1 | ARYLCYCLOBUTYLALKYL AMINES AND THEIR USE AS ANTIDEPRESSIVE MEDICINES | The Boots Company PLC (GB) | 1988-06-08 | — | — | EP | claimed |
| EP-0191542-A1 | Arylcyclobutylalkyl amines and their use as antidepressive medicines | The Boots Company PLC (GB) | 1986-08-20 | — | — | EP | claimed |